Search Orphan Drug Designations and Approvals
-
| Generic Name: | Purified Allogeneic Human Pancreatic Islets of Langerhans |
|---|---|
| Date Designated: | 05/01/2019 |
| Orphan Designation: | Treatment of Brittle Type 1 Diabetes |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
University of Chicago 5801 S Ellis Ave, Suite 619 Chicago, Illinois 60637 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







